Estimating the association of the 2017 and 2014 hypertension guidelines with cardiovascular events and deaths in US adults: An analysis of national data

JAMA Cardiology

Volumn 3, Issue 7, 2018, Pages 572-581

  Bundy, Joshua D ^a,b,c   Mills, Katherine T ^a,b   Chen, Jing ^a,b,d   Li, Changwei ^a   Greenland, Philip ^a,c   He, Jiang ^a,b,d  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ACUTE KIDNEY FAILURE; ADULT; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; MALE; MIDDLE AGED; MORTALITY; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; UNITED STATES; YOUNG ADULT; BLOOD PRESSURE; FOLLOW UP; FORECASTING; INCIDENCE; MEDICAL SOCIETY; NUTRITION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE;

ADULT; AMERICAN HEART ASSOCIATION; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; NUTRITION SURVEYS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 85051759395     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2018.1240     Document Type: Review

References (33)

1. Murray CJ, Atkinson C, Bhalla K, et al; U.S. Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013; 310(6):591-608.
2. Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016; 134(6):441-450.
3. Forouzanfar MH, Liu P, Roth GA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115mmHg, 1990-2015. JAMA. 2017; 317(2):165-182.
4. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: ameta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360(9349):1903-1913.
5. Wright JT Jr, Williamson JD, Whelton PK, et al; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373(22):2103-2116.
6. Williamson JD, Supiano MA, Applegate WB, et al; SPRINT Research Group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged-75 years: a randomized clinical trial. JAMA. 2016; 315(24):2673-2682.
7. Beddhu S, Rocco MV, Toto R, et al; SPRINT Research Group. Effects of intensive systolic blood pressure control on kidney and cardiovascular outcomes in persons without kidney disease: a secondary analysis of a randomized trial. Ann Intern Med. 2017; 167(6):375-383.
8. Bundy JD, Li C, Stuchlik P, et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis. JAMA Cardiol. 2017; 2(7): 775-781.
9. Whelton PK, Carey RM, AronowWS, et al. A guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J AmColl Cardiol. 2017. doi:10.1016/j.jacc.2017.11.006.
10. James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311(5):507-520.
11. Qaseem A, Wilt TJ, Rich R, Humphrey LL, Frost J, Forciea MA; Clinical Guidelines Committee of the American College of Physicians and the Commission on Health of the Public and Science of the American Academy of Family Physicians. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2017; 166(6):430-437.
12. Muntner P, Carey RM, Gidding S, et al. Potential U.S. population impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. J Am Coll Cardiol. 2018; 71(2):109-118.
13. Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999-2010. Vital Health Stat 1. 2013; (56):1-37.
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33(suppl 1):S62-S69.
15. Levey AS, Stevens LA, Schmid CH, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-612.
16. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129(25)(suppl 2):S49-S73.
17. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol. 1989; 129(4):687-702.
18. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991; 1(3):263-276.
19. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP. The Framingham Offspring Study: design and preliminary data. Prev Med. 1975; 4(4): 518-525.
20. Bild DE, Bluemke DA, Burke GL, et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002; 156(9):871-881.
21. Mozaffarian D, Benjamin EJ, Go AS, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2015 update: a report from the American Heart Association. Circulation. 2015; 131 (4):e29-e322.
22. Kochanek KD, Murphy SL, Xu J, Tejada-Vera B. Deaths: final data for 2014. Natl Vital Stat Rep. 2016; 65(4):1-122.
23. Achana FA, Cooper NJ, Dias S, et al. Extending methods for investigating the relationship between treatment effect and baseline risk from pairwise meta-analysis to network meta-analysis. Stat Med. 2013; 32(5):752-771.
24. Fishman G. Monte Carlo: Concepts, Algorithms, and Applications. New York: Springer-Verlag; 1999.
25. CushmanWC, Evans GW, Byington RP, et al; ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010; 362(17):1575-1585.
26. Margolis KL, Palermo L, Vittinghoff E, et al. Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial. J Gen Intern Med. 2014; 29(12):1599-1606.
27. Benavente OR, Coffey CS, Conwit R, et al; SPS3 Study Group. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013; 382(9891):507-515.
28. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988; 318 (26):1728-1733.
29. Bress AP, Bellows BK, King JB, et al; SPRINT Research Group. Cost-effectiveness of intensive versus standard blood-pressure control. N Engl J Med. 2017; 377(8):745-755.
30. Blood Pressure Lowering Treatment Trialists' Collaboration. Blood pressure-lowering treatment based on cardiovascular risk: ameta-analysis of individual patient data. Lancet. 2014; 384(9943): 591-598.
31. Turnbull F, Neal B, Ninomiya T, et al; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008; 336(7653):1121-1123.
32. Ninomiya T, Perkovic V, Turnbull F, et al; Blood Pressure Lowering Treatment Trialists' Collaboration. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ. 2013; 347:f5680.
33. Bundy JD, Whelton PK, He J. Safety vs efficacy of lowering blood pressure-reply. JAMA Cardiol. 2017; 2(12):1399-1400.